"Orthobond, a leader in covalently-bound antimicrobial surface treatments with broad applications in the medical device industry announced today the appointment of Frank P. Cammisa, MD, as the company’s Chief Medical Officer. In this role Dr. Cammisa will provide leadership in clinical research and commercial applications for the technology."
"Orthobond Unveils Anti-Microbial Surface Technology Designed to Destroy Pathogens on Contact at The American Academy of Orthopaedic Surgeons Annual Meeting"
"It’s hard to get through the first hour of the day without worrying about pathogens these days. Princeton, New Jersey-based Orthobond Corporation, is making a dent in this issue, having just released its patented antimicrobial nano surface technology at the American Academy of Orthopaedic Surgeons annual meeting in San Diego."